Adoptive cell transfer with lymphodepletion and high-dose interleukin-2
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adoptive cell transfer with lymphodepletion and high-dose interleukin-2, covering 2022-02-03 to 2022-02-03. Get the full timeline:
Most recent: Clinical Trial Update: Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic Melanoma [Phase 2]